Export 1889 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
Journal Article
Matos, A. J. F., Mascarenhas, C., Magalhães, P., & Pinto, J. P. (2006). Efficient screening of the cystinuria-related C663T Slc3a1 nonsense mutation in Newfoundland dogs by denaturing high-performance liquid chromatography. Journal of Veterinary Diagnostic Investigation, 18(1), 102 - 105.
Kramer, G., Wegdam, W., Donker-Koopman, W., Ottenhoff, R., et al. (2016). Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models. FEBS Open Bio, 6(9), 902 - 913.
Félix, L. M., Serafim, C., Valentim, A. M., Antunes, L. M., et al. (2016). Embryonic Stage-Dependent Teratogenicity of Ketamine in Zebrafish (Danio rerio). Chemical Research in Toxicology, 29(8), 1298 - 1309.
Maia, C., Catarino, A. L., Almeida, B., Ramos, C., et al. (2016). Emergence of Thelazia callipaeda Infection in Dogs and Cats from East-Central Portugal. Transboundary and emerging diseases, 63(4), 416 - 421.
Sequeiros, J., Martindale, J., & Seneca, S. (2010). EMQN Best Practice Guidelines for molecular genetic testing of SCAs. European Journal of Human Genetics, 18(11), 1173 - 1176.
Porto, G., Brissot, P., Swinkels, D. W., Zoller, H., et al. (2016). EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH). European Journal of Human Genetics, 24(4), 479 - 495.
Moraes, C. B., White, K. L., Braillard, S., Perez, C., et al. (2015). Enantiomers of nifurtimox do not exhibit stereoselective anti-Trypanosoma cruzi activity, toxicity, or pharmacokinetic properties. Antimicrobial Agents and Chemotherapy, 59(6), 3645 - 3647.
Fonseca, B. M., Correia-da-Silva, G., Taylor, A. H., Lam, P. M. W., et al. (2010). The endocannabinoid 2-arachidonoylglycerol (2-AG) and metabolizing enzymes during rat fetoplacental development: A role in uterine remodelling. International Journal of Biochemistry and Cell Biology, 42(11), 1884 - 1892.
Mesquita, F. S., Brito, C., Moya, M. J. Mazon, Pinheiro, J. C., et al. (2017). Endoplasmic reticulum chaperone Gp96 controls actomyosin dynamics and protects against pore-forming toxins. EMBO Reports, 18(2), 303 - 318.
Mesquita, F. S., Brito, C., Moya, M. J. Mazon, Pinheiro, J. C., et al. (2017). Endoplasmic reticulum chaperone Gp96 controls actomyosin dynamics and protects against pore-forming toxins. EMBO Reports, 18(2), 303 - 318.
Mesquita, F. S., Brito, C., Moya, M. J. Mazon, Pinheiro, J. C., et al. (2017). Endoplasmic reticulum chaperone Gp96 controls actomyosin dynamics and protects against pore-forming toxins. EMBO Reports, 18(2), 303 - 318.
Silva, M., Martins, D., Charrua, A., Piscitelli, F., et al. (2016). Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy. Neuropharmacology, 107, 49 - 57.
Silva, M., Martins, D., Charrua, A., Piscitelli, F., et al. (2016). Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy. Neuropharmacology, 107, 49 - 57.
Ascensão, A., Magalhães, J., Soares, J., Ferreira, R., et al. (2005). Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. International Journal of Cardiology, 100(3), 451 - 460.
Ascensão, A., Magalhães, J., Soares, J., Ferreira, R., et al. (2005). Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice. International Journal of Cardiology, 100(3), 451 - 460.
Ascensão, A., Magalhães, J., Soares, J. M. C., Ferreira, R., et al. (2006). Endurance training limits the functional alterations of heart rat mitochondria submitted to in vitro anoxia-reoxygenation. International Journal of Cardiology, 109(2), 169 - 178.
Ascensão, A., Magalhães, J., Soares, J. M. C., Ferreira, R., et al. (2006). Endurance training limits the functional alterations of heart rat mitochondria submitted to in vitro anoxia-reoxygenation. International Journal of Cardiology, 109(2), 169 - 178.
Harley, C. A., Starek, G., Jones, D. K., Fernandes, A. S., et al. (2016). Enhancement of hERG channel activity by scFv antibody fragments targeted to the PAS domain. Proceedings of the National Academy of Sciences of the United States of America, 113(35), 9916 - 9921.
Morais-Cabral, J. H., & Robertson, G. A. (2015). The enigmatic cytoplasmic regions of KCNH channels. Journal of Molecular Biology, 427(1), 67 - 76.
Teixeira, L., Marques, R. M., Ferreirinha, P., Bezerra, F., et al. (2016). Enrichment of IFN-γ producing cells in different murine adipose tissue depots upon infection with an apicomplexan parasite. Scientific Reports, 6.
Teixeira, L., Marques, R. M., Ferreirinha, P., Bezerra, F., et al. (2016). Enrichment of IFN-γ producing cells in different murine adipose tissue depots upon infection with an apicomplexan parasite. Scientific Reports, 6.
Teixeira, L., Marques, R. M., Ferreirinha, P., Bezerra, F., et al. (2016). Enrichment of IFN-γ producing cells in different murine adipose tissue depots upon infection with an apicomplexan parasite. Scientific Reports, 6.
Harmatz, P., Giugliani, R., Schwartz, I., Guffon, N., et al. (2006). Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-l. Journal of Pediatrics, 148(4), 533 - 533.e.
Harmatz, P., Yu, Z. - F., Giugliani, R., Schwartz, I. V. D., et al. (2010). Enzyme replacement therapy for mucopolysaccharidosis VI: Evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. Journal of Inherited Metabolic Disease, 33(1), 51 - 60.
Decker, C., Yu, Z. - F., Giugliani, R., Schwartz, I. V. D., et al. (2010). Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase. Journal of Pediatric Rehabilitation Medicine, 3(2), 89 - 100.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@i3s.up.pt | © copyright 2010 ibmc